Market Research Reports and Industry Reports

Global Gastrointestinal Partnering 2010-2016: Deal trends, players and financials

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
The Global Dermatology Partnering 2010-2016 report provides comprehensive understanding and unprecedented access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies The Global Dermatology Partnering 2010-2016: Deal trends, players and financials report provides an understanding and access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in Dermatology partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Dermatology partnering agreement structure
Dermatology partnering contract documents
Top Dermatology deals by value
Most active Dermatology dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensors product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive dermatology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Dermatology deals.

The report presents financial deal terms values for Dermatology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of dermatology dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in dermatology dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading dermatology deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active dermatology dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to dermatology deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all dermatology partnering deals by specific dermatology target announced since 2010. The chapter is organized by specific dermatology therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all dermatology partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in dermatology partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of dermatology technologies and products.

Contract documents provide the answers to numerous questions about a prospective partners flexibility on a wide range of important issues, many of which will have a significant impact on each partys ability to derive value from the deal.

Report scope

Global Dermatology Partnering 2010-2016 is intended to provide the reader with an in-depth understanding and access to dermatology trends and structure of deals entered into by leading companies worldwide.

Global Dermatology Partnering 2010-2016 includes:

Trends in dermatology dealmaking in the biopharma industry since 2010
Analysis of dermatology deal structure
Access to headline, upfront, milestone and royalty data
Access to over 700 dermatology deal records
The leading dermatology deals by value since 2010


The report includes deals for the following indications: Acne, Actinic keratosis, Angioedema, Burns, Cellulitis, Cosmetics, Dermatitis, Diabetic foot ulcer, Eczema, Hair disorders, Alopecia, Impetigo, Itching, Nail disorders, Psoriasis, Rosacea, Scabies, Sun damage, Rash, Scar, Venous ulcer, Verruca, Wound healing, Wrinkles, plus other dermatology indications.

In Global Dermatology Partnering 2010-2016, the available deals are listed by:

Company A-Z
Headline value
Stage of development at signing
Deal component type
Specific therapy target

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Dermatology Partnering 2010-2016 report provides comprehensive access to available deals and contract documents for over 650 dermatology deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How are the sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?


Executive Summary

Chapter 1 Introduction

Chapter 2 Trends in Gastrointestinal dealmaking

2.1. Introduction
2.2. Gastrointestinal partnering over the years
2.3. Gastrointestinal partnering by deal type
2.4. Gastrointestinal partnering by industry sector
2.5. Gastrointestinal partnering by stage of development
2.6. Gastrointestinal partnering by technology type
2.7. Gastrointestinal partnering by therapeutic indication

Chapter 3 Financial deal terms for Gastrointestinal partnering

3.1. Introduction
3.2. Disclosed financials terms for Gastrointestinal partnering
3.3. Gastrointestinal partnering headline values
3.4. Gastrointestinal deal upfront payments
3.5. Gastrointestinal deal milestone payments
3.6. Gastrointestinal royalty rates

Chapter 4 Leading Gastrointestinal deals and dealmakers

4.1. Introduction
4.2. Most active in Gastrointestinal partnering
4.3. List of most active dealmakers in Gastrointestinal
4.4. Top Gastrointestinal deals by value

Chapter 5 Gastrointestinal contract document directory

5.1. Introduction
5.2. Gastrointestinal partnering deals where contract document available

Chapter 6 Gastrointestinal dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Gastrointestinal therapeutic target

Appendices

Appendix 1 Directory of Gastrointestinal deals by company A-Z 2010 to 2016
Appendix 2 Directory of Gastrointestinal deals by deal type 2010 to 2016
Appendix 3 Directory of Gastrointestinal deals by stage of development 2010 to 2016
Appendix 4 Directory of Gastrointestinal deals by technology type 2010 to 2016

List Of Figures

Figure 1: Gastrointestinal partnering since 2010
Figure 2: Gastrointestinal partnering by deal type since 2010
Figure 3: Gastrointestinal partnering by industry sector since 2010
Figure 4: Gastrointestinal partnering by stage of development since 2010
Figure 5: Gastrointestinal partnering by technology type since 2010
Figure 6: Gastrointestinal partnering by indication since 2010
Figure 7: Gastrointestinal deals with a headline value
Figure 8: Gastrointestinal deals with upfront payment values
Figure 9: Gastrointestinal deals with milestone payment
Figure 10: Gastrointestinal deals with royalty rates
Figure 11: Active Gastrointestinal dealmaking activity 2010 to 2016
Figure 12: Top Gastrointestinal deals by value since 2010

Global Pressure Homogenizers Market Research Report 2016

2016 Global Pressure Homogenizers Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Pressure Homogenizers industry, focusing on the main regions

USD 2850View Report

Global Mechanical Homogenizers Market Research Report 2016

2016 Global Mechanical Homogenizers Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Mechanical Homogenizers industry, focusing on the main regions

USD 2850View Report

Global Smart Labels Market Research Report 2016

2016 Global Smart Labels Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Smart Labels industry, focusing on the main regions

USD 2850View Report

Global Gastrointestinal Endoscopic Devices Market Research Report 2016

2016 Global Gastrointestinal Endoscopic Devices Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Gastrointestinal Endoscopic Devices industry, focusing on the

USD 2850View Report

Global Gastrointestinal Device Market Research Report 2016

Notes:Production, means the output of Gastrointestinal DeviceRevenue, means the sales value of Gastrointestinal DeviceThis report studies Gastrointestinal Device in Global market, especially in North America, Europe, China, Japan, Southeast Asia

USD 2900View Report

Global Gastrointestinal OTC Drugs Sales Market Report 2016

Notes:Sales, means the sales volume of Gastrointestinal OTC DrugsRevenue, means the sales value of Gastrointestinal OTC DrugsThis report studies sales (consumption) of Gastrointestinal OTC Drugs in Global market, especially in

USD 4000View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Reports Details

Published Date : Nov -0001
No. of Pages :700
Country :Global
Category :Pharmaceuticals and Healthcare
Publisher :Wildwood Ventures Ltd.
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment